HSD17B13 and metabolic dysfunction-associated steatotic liver disease: This has subsequently been replicated in multiple genome‐wide analyses that also implicate these variants in levels of serum aminotransferases and liver disease in adults.[12, 13, 14]HSD17B13 has subsequently been validated in multiple cohorts of adults,[6, 16, 17, 33, 56, 57, 58] and although a small group of children were included in the original replication cohort where this variant was identified,[10] features specific to pediatric NAFLD histology were not described in detail.